SC 13D Filing

Company

Biodexa Pharmaceuticals Plc

Filed

April 4, 2019

Accession Number

0001214659-19-002560

A Schedule 13D is filed when an investor acquires more than 5% of a company's shares with an intent to influence control. Learn more about SC 13D filings →